TORNTPHARMTorrent Pharmaceuticals Limited
Convert to ideaPharmaceuticals & Biotechnology · Pharmaceuticals · India Ratings: AA+ (Positive)
The verdict combines business quality, price and timing. Sign in free to see it.
Sign in freeDown 0.4 this quarter.
Momentum from moving averages, Supertrend and RSI.
3 forensic issues found. Sign in to see which.
Valuation Metrics
Q2 FY2027Intrinsic value, Graham number and DCF against today's price
3 found · risk elevated
Quality, growth, balance sheet and earnings quality behind the score
ⓘ Based on fundamental & forensic analysis. Always verify against official filings and consult a financial advisor.
Financial Metrics
Comparing Q2 FY2027 vs Q2 FY2026
| Quarter | Revenue | Net Profit | OPM | NPM | EPS | Int. Cover |
|---|---|---|---|---|---|---|
| Q2 FY2027 | ₹4979 Cr | ₹534 Cr | 21.23% | 10.73% | ₹14.05 | 3.5x |
| Q1 FY2027 | ₹4921 Cr | ₹566 Cr | 21.76% | 11.50% | ₹14.87 | 3.4x |
| Q4 FY2026 | ₹4197 Cr | ₹364 Cr | 20.20% | 8.67% | ₹11.51 | 3.2x |
| Q3 FY2026 | ₹3303 Cr | ₹635 Cr | 26.70% | 19.22% | ₹18.77 | 19.1x |
| Q2 FY2026 | ₹3302 Cr | ₹591 Cr | 26.62% | 17.90% | ₹17.45 | 17.5x |
| Q1 FY2026 | ₹3178 Cr | ₹548 Cr | 26.15% | 17.24% | ₹16.19 | 14.2x |
Momentum score, 1-year chart, moving averages, support and resistance.
Turnaround stage, and how each measure moved over 3 years against the company's own range.
Order wins, capex, pledges, rating actions and every material filing.
Management guidance, Q&A highlights and whether they delivered what they said.
The earnings call read across investor dimensions.
Promoter, FII and mutual fund holding, and what changed this quarter.
Similar-size peers in Pharmaceuticals
Compare with peers →Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, cosmo-dermatology, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Limited.
Note: This comprehensive analysis combines technical data, fundamental data, and investment thesis. Always do your own research and consider your personal risk tolerance before investing.